The study to evaluate the efficacy and safety of Polynucleotide for Periorbital Rejuvenation in Thailand
Phase 4
Recruiting
- Conditions
- HealthyPolynucleotide, Periorbital Rejuvenation
- Registration Number
- TCTR20230214003
- Lead Sponsor
- SW HEALTHCARE CO.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
1. Aged 25-55 years old
2. Both male and female
3. Grade 1-5 wrinkle at periorbital by Wrinkle Assessment Scale of periorbital lines
Exclusion Criteria
1. Subjects who are pregnant
2. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin
3. Subjects who has dermatits, wound or infection at treatment area
4. Subjects who allergy to anesthesia cream
5. Subjects who taken oral or injection contraceptive pills
6. Subjects who had history of laser, filler and botox at treatment area within 6 months before arrived the project
7. Subjects who had history of keloid or hypertrophic scar
8. Subjects who had history of psychitic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average Wrinkle and Texture Baseline, 1 month after 1st treatment, 1 months after 2nd treatment, 1 month, 3 months, 6 months after the last treatments. Antera
- Secondary Outcome Measures
Name Time Method